The Fund announced that it has commenced an underwritten public offering of common shares of beneficial interest pursuant to the Fund’s effective shelf registration statement filed with the U.S. Securities and Exchange Commission. The Trust also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent of the Common Shares sold to cover over-allotments, if any. The final terms of the offering will depend on market and other conditions at the time of pricing, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. As of 2021-07-20, the Fund’s leverage was 38.7% and Loan Participation Group leverage was 31.8%.